BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2666051)

  • 21. Multiple genetic alterations in distal and proximal colorectal cancer.
    Delattre O; Olschwang S; Law DJ; Melot T; Remvikos Y; Salmon RJ; Sastre X; Validire P; Feinberg AP; Thomas G
    Lancet; 1989 Aug; 2(8659):353-6. PubMed ID: 2569552
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular abnormalities of p53, MDM2, and H-ras in synovial sarcoma.
    Oda Y; Sakamoto A; Satio T; Kawauchi S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2000 Sep; 13(9):994-1004. PubMed ID: 11007040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of G-to-T transversions among K-ras oncogene mutations in human colorectal tumors in Yugoslavia.
    Urosević N; Krtolica K; Skaro-Milić A; Knezević-Usaj S; Dujić A
    Int J Cancer; 1993 May; 54(2):249-54. PubMed ID: 8486427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
    Zhang X; Wang Y; Gao N; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ploidy in colorectal cancer].
    Remvikos J; Muleris M; Vielh P; Zafrani B; Thomas G; Dutrillaux B; Girodet J; Salmon RJ
    Gastroenterol Clin Biol; 1987 Oct; 11(10):681-5. PubMed ID: 3692091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
    Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
    Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma.
    Wilentz RE; Chung CH; Sturm PD; Musler A; Sohn TA; Offerhaus GJ; Yeo CJ; Hruban RH; Slebos RJ
    Cancer; 1998 Jan; 82(1):96-103. PubMed ID: 9428484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
    Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
    Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A possible multiclonal development in human colonic carcinomas.
    Ohmura M; Hattori T
    J Cancer Res Clin Oncol; 1995; 121(6):321-6. PubMed ID: 7797596
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of p53, MDM2, and H-ras genes in osteosarcoma and malignant fibrous histiocytoma of bone in patients older than 40 years.
    Kawaguchi K; Oda Y; Sakamoto A; Saito T; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2002 Aug; 15(8):878-88. PubMed ID: 12181274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prognostic value of the presence of the mutation of the codons 12, 13 and 61 in K-ras oncogene in colorectal cancer].
    Pajkos G; Kiss I; Sándor J; Ember I; Kisházi P
    Orv Hetil; 1999 Jul; 140(30):1673-9. PubMed ID: 10461447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amplification of c-myc oncogene and absence of c-Ha-ras point mutation in human bone sarcoma.
    Barrios C; Castresana JS; Ruiz J; Kreicbergs A
    J Orthop Res; 1993 Jul; 11(4):556-63. PubMed ID: 8101872
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutations of APC and K-ras gene in aberrant crypt foci from human colon].
    Yuan P; Sun M; Zhang J; Zhu X; Shi D
    Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):35-8. PubMed ID: 11866955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of K-ras and TP53 mutations in the role of adjuvant chemotherapy on survival in patients with Dukes C colon cancer.
    Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Verlind E; Hermans J; Poppema S; Buys CH; Plukker JT
    Dis Colon Rectum; 2001 Mar; 44(3):358-63. PubMed ID: 11289281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of c-ras gene mutation and expression of p21 protein in dysplasias and carcinomas complicating ulcerative colitis.
    Tsuda T; Mochizuki M; Wakasa H
    J Gastroenterol; 1995 Nov; 30 Suppl 8():30-2. PubMed ID: 8563883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [p21ras expression, DNA ploidy and prognosis in colorectal cancer].
    Wang S; Yu YX; Zhang JQ
    Zhonghua Wai Ke Za Zhi; 1994 Aug; 32(8):480-2. PubMed ID: 7882773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ras p21 oncoprotein expression in human colonic neoplasia--an immunohistochemical study with monoclonal antibody RAP-5.
    Lanza G
    Histopathology; 1988 Jun; 12(6):595-609. PubMed ID: 3047043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency and spectrum of c-Ki-ras mutations in human sporadic colon carcinoma, carcinomas arising in ulcerative colitis, and pancreatic adenocarcinoma.
    Burmer GC; Rabinovitch PS; Loeb LA
    Environ Health Perspect; 1991 Jun; 93():27-31. PubMed ID: 1773797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Detection of the expression of P21, P53, P185 proteins and the mutation of ras, p53 genes in colorectal adenoma and carcinoma].
    Liang Z; Liu F; Luo Y
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):352-5. PubMed ID: 8732090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.